ConductScience.org, home

Gene · 2492

Papers3,947

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

301 to 320 of 3,947

Download this page as JSON
TitleJournalYearPMIDFound bySource
A Journey to Reach the Ovary Using Next-Generation Technologies.Int J Mol Sci202338068916PubTator, text miningPubMed
Recent Advances in Folates and Autoantibodies against Folate Receptors in Early Pregnancy and Miscarriage.Nutrients202338068740PubTator, text miningPubMed
Comparative Transcriptome Analysis Reveals Sexually Dimorphic Gene Expression in the Gonads of Brachymystax tsinlingensis Li.Animals (Basel)202338067041PubTator, text miningPubMed
[Prognostic model for assessing the human glioma cell malignancy grade based on MDM2, MELK, SOX2, CDK4, DR5 and OCT4 gene expression].Zh Vopr Neirokhir Im N N Burdenko202338054226PubTator, text miningPubMed
Research progress on the premature ovarian failure caused by cisplatin therapy.Front Oncol202338053654PubTator, text miningPubMed
25(OH)D3 improves granulosa cell proliferation and IVF pregnancy outcomes in patients with endometriosis by increasing G2M+S phase cells.Reprod Biol Endocrinol202338053145PubTator, text miningPubMed
Structure, function and drug discovery of GPCR signaling.Mol Biomed202338047990PubTator, text miningPubMed
Clinical evidence of growth hormone for infertile women with diminished ovarian reserve undergoing IVF: a systematic review and meta-analysis.Front Endocrinol (Lausanne)202338027219PubTator, text miningPubMed
An algorithm for drug discovery based on deep learning with an example of developing a drug for the treatment of lung cancer.Front Bioinform202338025397PubTator, text miningPubMed
A Review on Treatment of Premature Ovarian Insufficiency: Characteristics, Limitations, and Challenges of Stem Cell versus ExosomeTherapy.Vet Med Int202338023426PubTator, text miningPubMed
Luteinizing Hormone/Human Chorionic Gonadotropin Receptor N312S Single-Nucleotide Polymorphism and Its Impact on Clinical and Reproductive Outcomes in Assisted Reproductive Technology: A Prospective Cohort Study.
Cureus202338022167PubTator, text miningPubMed
Significantly shortened telomere length and altered androgen receptor level in cumulus cells from women with polycystic ovary syndrome.Taiwan J Obstet Gynecol202338008503PubTator, text miningPubMed
A review of nitric oxide and oxidative stress in typical ovulatory women and in the pathogenesis of ovulatory dysfunction in PCOS.Reprod Biol Endocrinol202337996893PubTator, text miningPubMed
In vitro maturation (IVM) of human immature oocytes: is it still relevant?Reprod Biol Endocrinol202337993914PubTator, text miningPubMed
Follicular reconstruction and neo-oogenesis in xenotransplantation of human ovarian isolated cells derived from chemotherapy-induced POF patients.J Biol Eng202337986177PubTator, text miningPubMed
Are higher follicle-stimulating hormone levels before androgen deprivation therapy for prostate cancer associated with oncological and cardiac outcomes and overall survival?-a population-level analysis.
Transl Androl Urol202337969776PubTator, text miningPubMed
Maximum intensity projection based on high frame rate contrast-enhanced ultrasound for the differentiation of breast tumors.Front Oncol202337965464PubTator, text miningPubMed
Expression of genes and enzymes involved in ovarian steroidogenesis in relation to human follicular development.Front Endocrinol (Lausanne)202337964966PubTator, text miningPubMed
Single-cell sequencing reveals the reproductive variations between primiparous and multiparous Hu ewes.J Anim Sci Biotechnol202337964337PubTator, text miningPubMed
Oocyte Cryopreservation in Women with Ovarian Endometriosis.J Clin Med202337959232PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2492/papers?page=16